NCT03497572View on ClinicalTrials.gov

Seroprevalence Study to Evaluate the Persistence of Anti-leptospira Antibody in Subjects Vaccinated With Spirolept® Vaccine

CompletedOBSERVATIONAL
Enrollment

145

Participants

Timeline

Start Date

August 25, 2017

Primary Completion Date

April 12, 2018

Study Completion Date

April 12, 2018

Conditions
Leptospirosis
Trial Locations (2)

75013

Mairie de Paris, Paris

78603

SIAAP, Maisons-Laffitte

Sponsors

Lead Sponsor

Imaxio
All Listed Sponsors
lead

Imaxio

INDUSTRY